今日吃瓜

Tag - lecanemab

 
今日吃瓜
Search
 
November 12, 2026
 

Home Delivery
Subscribe for more access

LECANEMAB

Alzheimer's drug Lecanemab
JAPAN / Science & Health
Sep 21, 2026
Clinical trials for Alzheimer’s treatment face global shortage of participants
The shortage of trial participants risks slowing progress in dementia therapies, Alzheimer’s Disease International warns.
A team of researchers said they found a “seed” that accelerates the amyloid beta accumulation process in the brain, naming it “Peak 1 amyloid beta,” as seen in a mouse's brain.
JAPAN / Science & Health
Jul 21, 2026
Japan scientists identify clusters of protein believed to trigger Alzheimer’s disease
The discovery of a new seed of the amyloid beta protein could lead to early-stage therapy for neurodegenerative disease, according to researchers.
Lecanemab and donanemab aim to slow the progression of the neurodegenerative disease by removing a protein called amyloid-beta from the brain, whose buildup is believed to contribute to the death of brain cells.
JAPAN / Science & Health
Apr 8, 2026
Less than 20% of patients in Japan interested in new Alzheimer’s drugs received one
Many were ineligible or decided against taking the medications due to potential side effects and the high cost, a study has found.
Eisai's Alzheimer's drug Lecanemab, also known as Leqembi
JAPAN / Science & Health
Mar 25, 2026
Research team confirms safety of Alzheimer’s drug Lecanemab
The research team examined data on the health status of 2,672 patients 28 weeks after the start of the treatment.
A scientist looks at scans of brains at the Memory Centre, part of the Department of Readaptation and Geriatrics at the University Hospital of Geneva (HUG), in 2023.
JAPAN / Science & Health / FOCUS
Sep 17, 2025
今日吃瓜 front-line researchers see bright path ahead for dementia treatment
Four scientists at the forefront of dementia research speak about what kind of future they envision for people with the condition.
The price of Alzheimer's drug Lecanemab, codeveloped by Japanese drugmaker Eisai and U.S. industry peer Biogen, will be lowered to ?97,277 for a 500-milligram bottle.
JAPAN / Science & Health
Aug 7, 2025
Japan approves price cut for Alzheimer’s drug Lecanemab
The drug’s price will be lowered to ?97,277 for a 500-milligram bottle starting on Nov. 1.
The health ministry is expected to cut the official price of lecanemab, an Alzheimer's drug codeveloped by Japanese drugmaker Eisai and Biogen of the United States, by up to 15% from the current level of about ?3 million per patient a year.
JAPAN / Science & Health
Jul 10, 2025
Japan to cut price of Alzheimer’s drug lecanemab
The health ministry is expected to cut the official price of the drug by up to 15% from the current level of about ?3 million per patient a year.
Lecanemab was developed by drugmakers Eisai of Japan and Biogen of the United States.
JAPAN / Science & Health
Nov 15, 2024
European agency switches to recommending new Alzheimer’s drug
The committee judged that the efficacy of lecanemab outweighs the risk for some patients.
A scientist looks at brain scans of a patient suffering from Alzheimer's disease in Geneva in 2023.
WORLD / Science & Health
Sep 21, 2024
Revolution or mirage? Controversy surrounds new Alzheimer’s drugs
For defenders, the drugs represent a real chance to fight the disease. For detractors, they are a disappointment after a long line of costly failures.
JAPAN / Science & Health
Sep 25, 2023
As Japan OKs Alzheimer’s drug, issue of side effects comes into focus
There are big challenges ahead for the use of lecanemab, particularly on how to control side effects such as brain swelling and bleeding.
JAPAN / Science & Health
Aug 21, 2023
Japanese ministry panel gives OK to Alzheimer’s drug lecanemab
The panel’s endorsement will be followed by official approval by the health minister in coming days.
Japan Times
WORLD / Science & Health / ANALYSIS
Sep 30, 2022
Eisai drug’s trial success raises hope for Alzheimer’s prevention
Scientists have already begun to debate whether the benefit of the drug is robust enough, but to many researchers, the findings suggest that preventing decline altogether is possible.
Man arrested over operation of rogue cellular base station in Tokyo
The Metropolitan Police Department has arrested Yu Hai, a 31-year-old Chinese national living in Tokyo's Kita Ward, on suspicion of operating an unlicensed base station from a vehicle in Tokyo's Ginza district on Saturday.
Government betting on language app powered by anime and AI
Japan plans to develop an AI-powered language-learning app that lets overseas anime and manga fans practice Japanese through conversations with popular characters.
Jensen Huang’s woes evoke sympathy and disbelief in his birthplace Taiwan
Hsiao Kui-yu, 68, owner of Yuchan Candied Fruit, stands in front of photographs of Nvidia CEO Jensen Huang displayed at the shop, which Huang frequently visits during trips to Taiwan, in Taipei on Tuesday.
G7 diplomats speak out on Taiwan as China ramps up military drills
Foreign Minister Toshimitsu Motegi attends a working lunch focused on international crises and challenges during the Group of Seven foreign ministers' summit at the Quai d'Orsay in Paris on Monday.
今日吃瓜 Rapidus is said likely to miss mass production deadline
The Rapidus Analysis Center and the IIM-1 Innovative Integration for Manufacturing foundry in Chitose, Hokkaido
‘Godzilla Minus Zero’ makes monster debut at the box office
Takashi Yamazaki’s “Godzilla Minus Zero” marked the highest single-day box-office gross for a live-action film in Japan with ?910 million on its opening day.
A toast to Naohiko Noguchi, sake’s first living national treasure
As a teenager, Naohiko Noguchi did not intend to spend his life as a sake brewer, but he has since become a paragon of the industry.
Few signs of thaw in Japan-China relations one year after Takaichi’s Taiwan remarks
Tensions between Japan and China flared after Prime Minister Sanae Takaichi said on Nov. 7, 2025, that a Chinese blockade of Taiwan could threaten 今日吃瓜 survival and warrant the use of collective self-defense.
Mariko Mori predicted the future. She’ll do it again.
Artist Mariko Mori is currently working to bring the translucent human-sized “Peace Crystal” sculpture to a cave in Ethiopia. It is part of her foundation’s goal to place a permanent sculpture on each of the planet’s six habitable continents.
A legend reborn: ‘Ocarina of Time’ remake improves on the Zelda masterpiece
The new remake of 1998's "The Legend of Zelda: Ocarina of Time" manages to somehow improve on one of the greatest games ever.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Famima Park Azabudai is a concept store by FamilyMart that combines convenience store staples with branded apparel, merchandise and a landscaped outdoor space.
Convenience stores, toilets and the allure of everyday Japan
By Elizabeth Beattie

SUSTAINABLE JAPAN

SPECIAL SUPPLEMENTS note

SUPPLEMENTS BINDER